Report Overview
Cell therapy contract manufacturing organizations (CMOs) specialize in providing outsourced development and production services for cell-based therapies, which involve the administration of living cells to treat or prevent diseases. These therapies include autologous (patient-specific) and allogeneic (off-the-shelf) treatments, such as CAR-T cell therapies, stem cell therapies, and regenerative medicine products. The market is driven by the increasing demand for personalized medicine, advancements in cell and gene therapy technologies, and the growing number of clinical trials for novel therapies. However, challenges such as high manufacturing costs, complex regulatory requirements, and scalability issues persist. The competitive landscape includes both large, established CMOs and specialized niche players, with significant investment flowing into capacity expansion to meet rising demand. Geographically, North America dominates due to strong biopharma infrastructure and funding, while Asia-Pacific is emerging as a key growth region due to cost advantages and increasing government support. The market is projected to expand rapidly as more therapies gain regulatory approval and commercial adoption increases.
The global Cell Therapy Cmo market size was estimated at USD 2502.75 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 15.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cell Therapy Cmo market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cell Therapy Cmo market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cell Therapy Cmo market.
Global Cell Therapy Cmo Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Charles River
The Discovery Labs
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith
ThermoGenesis
Anemocyte
Thermo Fisher Scientific
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio
Market Segmentation (by Type)
Stem Cell
Non-Stem Cell
Market Segmentation (by Application)
Commercial
Academic Research
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cell Therapy Cmo Market
Overview of the regional outlook of the Cell Therapy Cmo Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell Therapy Cmo Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cell Therapy Cmo, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Cell Therapy Cmo
1.2 Key Market Segments
1.2.1 Cell Therapy Cmo Segment by Type
1.2.2 Cell Therapy Cmo Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Cell Therapy Cmo Market Overview
2.1 Global Market Overview
2.1.1 Global Cell Therapy Cmo Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Cell Therapy Cmo Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Cell Therapy Cmo Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Cell Therapy Cmo Product Life Cycle
3.3 Global Cell Therapy Cmo Sales by Manufacturers (2020-2025)
3.4 Global Cell Therapy Cmo Revenue Market Share by Manufacturers (2020-2025)
3.5 Cell Therapy Cmo Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cell Therapy Cmo Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Cell Therapy Cmo Market Competitive Situation and Trends
3.8.1 Cell Therapy Cmo Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cell Therapy Cmo Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Cell Therapy Cmo Industry Chain Analysis
4.1 Cell Therapy Cmo Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Cell Therapy Cmo Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cell Therapy Cmo Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cell Therapy Cmo Market
5.7 ESG Ratings of Leading Companies
6 Cell Therapy Cmo Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell Therapy Cmo Sales Market Share by Type (2020-2025)
6.3 Global Cell Therapy Cmo Market Size Market Share by Type (2020-2025)
6.4 Global Cell Therapy Cmo Price by Type (2020-2025)
7 Cell Therapy Cmo Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell Therapy Cmo Market Sales by Application (2020-2025)
7.3 Global Cell Therapy Cmo Market Size (M USD) by Application (2020-2025)
7.4 Global Cell Therapy Cmo Sales Growth Rate by Application (2020-2025)
8 Cell Therapy Cmo Market Sales by Region
8.1 Global Cell Therapy Cmo Sales by Region
8.1.1 Global Cell Therapy Cmo Sales by Region
8.1.2 Global Cell Therapy Cmo Sales Market Share by Region
8.2 Global Cell Therapy Cmo Market Size by Region
8.2.1 Global Cell Therapy Cmo Market Size by Region
8.2.2 Global Cell Therapy Cmo Market Size Market Share by Region
8.3 North America
8.3.1 North America Cell Therapy Cmo Sales by Country
8.3.2 North America Cell Therapy Cmo Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cell Therapy Cmo Sales by Country
8.4.2 Europe Cell Therapy Cmo Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cell Therapy Cmo Sales by Region
8.5.2 Asia Pacific Cell Therapy Cmo Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cell Therapy Cmo Sales by Country
8.6.2 South America Cell Therapy Cmo Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cell Therapy Cmo Sales by Region
8.7.2 Middle East and Africa Cell Therapy Cmo Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Cell Therapy Cmo Market Production by Region
9.1 Global Production of Cell Therapy Cmo by Region(2020-2025)
9.2 Global Cell Therapy Cmo Revenue Market Share by Region (2020-2025)
9.3 Global Cell Therapy Cmo Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cell Therapy Cmo Production
9.4.1 North America Cell Therapy Cmo Production Growth Rate (2020-2025)
9.4.2 North America Cell Therapy Cmo Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cell Therapy Cmo Production
9.5.1 Europe Cell Therapy Cmo Production Growth Rate (2020-2025)
9.5.2 Europe Cell Therapy Cmo Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cell Therapy Cmo Production (2020-2025)
9.6.1 Japan Cell Therapy Cmo Production Growth Rate (2020-2025)
9.6.2 Japan Cell Therapy Cmo Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cell Therapy Cmo Production (2020-2025)
9.7.1 China Cell Therapy Cmo Production Growth Rate (2020-2025)
9.7.2 China Cell Therapy Cmo Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Charles River
10.1.1 Charles River Basic Information
10.1.2 Charles River Cell Therapy Cmo Product Overview
10.1.3 Charles River Cell Therapy Cmo Product Market Performance
10.1.4 Charles River Business Overview
10.1.5 Charles River SWOT Analysis
10.1.6 Charles River Recent Developments
10.2 The Discovery Labs
10.2.1 The Discovery Labs Basic Information
10.2.2 The Discovery Labs Cell Therapy Cmo Product Overview
10.2.3 The Discovery Labs Cell Therapy Cmo Product Market Performance
10.2.4 The Discovery Labs Business Overview
10.2.5 The Discovery Labs SWOT Analysis
10.2.6 The Discovery Labs Recent Developments
10.3 BIOCENTRIQ
10.3.1 BIOCENTRIQ Basic Information
10.3.2 BIOCENTRIQ Cell Therapy Cmo Product Overview
10.3.3 BIOCENTRIQ Cell Therapy Cmo Product Market Performance
10.3.4 BIOCENTRIQ Business Overview
10.3.5 BIOCENTRIQ SWOT Analysis
10.3.6 BIOCENTRIQ Recent Developments
10.4 FUJIFILM Diosynth Biotechnologies
10.4.1 FUJIFILM Diosynth Biotechnologies Basic Information
10.4.2 FUJIFILM Diosynth Biotechnologies Cell Therapy Cmo Product Overview
10.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy Cmo Product Market Performance
10.4.4 FUJIFILM Diosynth Biotechnologies Business Overview
10.4.5 FUJIFILM Diosynth Biotechnologies Recent Developments
10.5 Exothera
10.5.1 Exothera Basic Information
10.5.2 Exothera Cell Therapy Cmo Product Overview
10.5.3 Exothera Cell Therapy Cmo Product Market Performance
10.5.4 Exothera Business Overview
10.5.5 Exothera Recent Developments
10.6 WuXi AppTec
10.6.1 WuXi AppTec Basic Information
10.6.2 WuXi AppTec Cell Therapy Cmo Product Overview
10.6.3 WuXi AppTec Cell Therapy Cmo Product Market Performance
10.6.4 WuXi AppTec Business Overview
10.6.5 WuXi AppTec Recent Developments
10.7 Pharmaron
10.7.1 Pharmaron Basic Information
10.7.2 Pharmaron Cell Therapy Cmo Product Overview
10.7.3 Pharmaron Cell Therapy Cmo Product Market Performance
10.7.4 Pharmaron Business Overview
10.7.5 Pharmaron Recent Developments
10.8 OBiO
10.8.1 OBiO Basic Information
10.8.2 OBiO Cell Therapy Cmo Product Overview
10.8.3 OBiO Cell Therapy Cmo Product Market Performance
10.8.4 OBiO Business Overview
10.8.5 OBiO Recent Developments
10.9 Cell Therapies
10.9.1 Cell Therapies Basic Information
10.9.2 Cell Therapies Cell Therapy Cmo Product Overview
10.9.3 Cell Therapies Cell Therapy Cmo Product Market Performance
10.9.4 Cell Therapies Business Overview
10.9.5 Cell Therapies Recent Developments
10.10 AGC Biologics
10.10.1 AGC Biologics Basic Information
10.10.2 AGC Biologics Cell Therapy Cmo Product Overview
10.10.3 AGC Biologics Cell Therapy Cmo Product Market Performance
10.10.4 AGC Biologics Business Overview
10.10.5 AGC Biologics Recent Developments
10.11 Cytiva
10.11.1 Cytiva Basic Information
10.11.2 Cytiva Cell Therapy Cmo Product Overview
10.11.3 Cytiva Cell Therapy Cmo Product Market Performance
10.11.4 Cytiva Business Overview
10.11.5 Cytiva Recent Developments
10.12 Helixmith
10.12.1 Helixmith Basic Information
10.12.2 Helixmith Cell Therapy Cmo Product Overview
10.12.3 Helixmith Cell Therapy Cmo Product Market Performance
10.12.4 Helixmith Business Overview
10.12.5 Helixmith Recent Developments
10.13 ThermoGenesis
10.13.1 ThermoGenesis Basic Information
10.13.2 ThermoGenesis Cell Therapy Cmo Product Overview
10.13.3 ThermoGenesis Cell Therapy Cmo Product Market Performance
10.13.4 ThermoGenesis Business Overview
10.13.5 ThermoGenesis Recent Developments
10.14 Anemocyte
10.14.1 Anemocyte Basic Information
10.14.2 Anemocyte Cell Therapy Cmo Product Overview
10.14.3 Anemocyte Cell Therapy Cmo Product Market Performance
10.14.4 Anemocyte Business Overview
10.14.5 Anemocyte Recent Developments
10.15 Thermo Fisher Scientific
10.15.1 Thermo Fisher Scientific Basic Information
10.15.2 Thermo Fisher Scientific Cell Therapy Cmo Product Overview
10.15.3 Thermo Fisher Scientific Cell Therapy Cmo Product Market Performance
10.15.4 Thermo Fisher Scientific Business Overview
10.15.5 Thermo Fisher Scientific Recent Developments
10.16 CBM
10.16.1 CBM Basic Information
10.16.2 CBM Cell Therapy Cmo Product Overview
10.16.3 CBM Cell Therapy Cmo Product Market Performance
10.16.4 CBM Business Overview
10.16.5 CBM Recent Developments
10.17 Bio Elpida
10.17.1 Bio Elpida Basic Information
10.17.2 Bio Elpida Cell Therapy Cmo Product Overview
10.17.3 Bio Elpida Cell Therapy Cmo Product Market Performance
10.17.4 Bio Elpida Business Overview
10.17.5 Bio Elpida Recent Developments
10.18 Genezen
10.18.1 Genezen Basic Information
10.18.2 Genezen Cell Therapy Cmo Product Overview
10.18.3 Genezen Cell Therapy Cmo Product Market Performance
10.18.4 Genezen Business Overview
10.18.5 Genezen Recent Developments
10.19 CCRM
10.19.1 CCRM Basic Information
10.19.2 CCRM Cell Therapy Cmo Product Overview
10.19.3 CCRM Cell Therapy Cmo Product Market Performance
10.19.4 CCRM Business Overview
10.19.5 CCRM Recent Developments
10.20 RoslinCT
10.20.1 RoslinCT Basic Information
10.20.2 RoslinCT Cell Therapy Cmo Product Overview
10.20.3 RoslinCT Cell Therapy Cmo Product Market Performance
10.20.4 RoslinCT Business Overview
10.20.5 RoslinCT Recent Developments
10.21 GenScript ProBio
10.21.1 GenScript ProBio Basic Information
10.21.2 GenScript ProBio Cell Therapy Cmo Product Overview
10.21.3 GenScript ProBio Cell Therapy Cmo Product Market Performance
10.21.4 GenScript ProBio Business Overview
10.21.5 GenScript ProBio Recent Developments
11 Cell Therapy Cmo Market Forecast by Region
11.1 Global Cell Therapy Cmo Market Size Forecast
11.2 Global Cell Therapy Cmo Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cell Therapy Cmo Market Size Forecast by Country
11.2.3 Asia Pacific Cell Therapy Cmo Market Size Forecast by Region
11.2.4 South America Cell Therapy Cmo Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cell Therapy Cmo by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Cell Therapy Cmo Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Cell Therapy Cmo by Type (2026-2033)
12.1.2 Global Cell Therapy Cmo Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Cell Therapy Cmo by Type (2026-2033)
12.2 Global Cell Therapy Cmo Market Forecast by Application (2026-2033)
12.2.1 Global Cell Therapy Cmo Sales (K Units) Forecast by Application
12.2.2 Global Cell Therapy Cmo Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key Findings
